Larvol

Larvol is a privately held company based in San Francisco, California, with a workforce of 164 employees. The company generated $35.7 million in revenue. Larvol specializes in providing customized intelligence reports and software as a service (SaaS) solutions to the healthcare and life sciences industries. Their product offerings include KOL monitoring, real-time news updates on high-impact developments, an intuitive cancer biomarker database, and comprehensive conference planning tools. These solutions are designed to help healthcare and life sciences experts make informed strategic decisions. LARVOL's approach combines extensive therapeutic area expertise with technological innovation. Their team of medical doctors and PhDs gathers data from over 25,000 sources, distilling the most critical findings into concise reports that offer real-time insights and time-saving analysis. Their team has a particular focus on oncology, inflammation, cardiovascular, and central nervous system (CNS) therapeutic areas. For further information about Larvol and its services, please visit their website at larvol.com.